Cargando…
Elevated Lipoprotein(a) Levels and Atrial Fibrillation: A Systematic Review
OBJECTIVE: The role of lipoprotein(a) (Lp[a]) as a possibly causal risk factor for atherosclerotic cardiovascular disease has been well established. However, the clinical evidence regarding the association between Lp(a) levels and atrial fibrillation (AF) remains limited and inconsistent. This study...
Autores principales: | Masson, Walter, Barbagelata, Leandro, Nogueira, Juan P, Corral, Pablo, Lavalle-Cobo, Augusto, Romeo, Francisco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Lipidology and Atherosclerosis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548189/ https://www.ncbi.nlm.nih.gov/pubmed/37800104 http://dx.doi.org/10.12997/jla.2023.12.3.267 |
Ejemplares similares
-
Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis
por: Masson, Walter, et al.
Publicado: (2021) -
Relationship between lipoproteins, thrombosis, and atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2021) -
Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study
por: Li, Zhi-Zhao, et al.
Publicado: (2022) -
Screening program for familial hyperchylomicronemia syndrome detection: Experience of a university health system
por: Masson, Walter, et al.
Publicado: (2023) -
Cardiopulmonary Exercise Testing in Patients with Post-COVID-19 Syndrome
por: Barbagelata, Leandro, et al.
Publicado: (2022)